December 1 (Fri) - 2 (Sat) , 2023
BEXCO, Busan, Korea
Korea Research Institute of Bioscience and Biotechnology (KRIBB), Korea
Cellular Reprogramming and Regenerative Therapy for Parkinson’s Disease
Hanyang University College of Medicine, Korea
Gene Therapy for Parkinson’s Disease Using the Combined Expression of the Midbrain Factors Nurr1 and Foxa2
University of Malaya, Malaysia
Microbiome-based Therapeutics for Parkinson's Disease
University of Pennsylvania, USA
Contextual Models for Reconstructing and Understanding Synucleinopathies - Seeding is Believing
Seoul National University College of Medicine, Korea
Role of Neuroinflammation in Developing Compound Proteinopathies
National Institutes for Quantum Science and Technology
Imaging α-synuclein Pathologies in Parkinson’s Disease and Related Disorders
The University of Tokyo, Japan
Repetitive Transcranial Magnetic Stimulation
Institute of Neurosciences, Kolkata, India
Peripheral Nerve/Muscle Stimulation in Movement Disorders
Dongguk University, Dongguk University Ilsan Hospital, Korea
Transcranial Direct Current Stimulation for Treatment of Movement Disorders
University Medical Center Goettingen, Germany
Unraveling the Molecular Basis of Synucleinopathies: from Biology to Pathology
National Institute of Mental Health & Neurosciences (NIMHANS), India
Non-pharmacological Therapies for Parkinson's Disease
Inje University College of Medicine, Korea
Update on Treatments for Nonmotor Symptoms of Parkinson's Disease
Gachon University Gil Medical Center, Korea
Dynamics of Neuromelanin and Iron Changes in PD and Atypical Parkinsonism
Clínica Universidad de Navarra, Pamplona-Madrid, Spain
Longitudinal Functional MRI Studies in Parkinson’s Disease
University Hospital of Cologne, Germany
Molecular Imaging and Connectomics in Neurodegeneration